PSMA PET/CT staging in intermediate-risk prostate cancer: Toward risk-adapted implementation. Petrelli F, Motta F, Bodrato S, De Stefani A, et al. Semin Oncol 2026;53:152504.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Petrelli F, Motta F, Bodrato S, De Stefani A, et al. PSMA PET/CT staging in intermediate-risk prostate cancer: Toward risk-adapted implementation. Semin Oncol 2026;53:152504.
PMID: 42320333